Many Patients With Systemic Lupus Erythematosus Use Opioids
Among SLE patients, likelihood of prescription opioids up for those using emergency department
Among SLE patients, likelihood of prescription opioids up for those using emergency department
The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.
No association was found between current statin use and the risk of developing systemic lupus erythematosus.
Diffuse alveolar hemorrhage in childhood-onset SLE is associated with serious disease flares, and is complicated by sepsis and high mortality rate.
Researchers have created a set of 21 candidate criteria for systemic lupus erythematosus as apart of a multiphase development of a set of criteria for the disease.
Fractional exhaled nitric oxide monitoring may provide a potential biomarker of disease activity and signify the emergency of pulmonary involvement in children with SLE.
Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.
The risk for death associated with SLE remains high for patients with SLE-associated PAH and researchers have identified the biomarkers that may lead to early detection.
Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.
Cumulative steroid dosage is a risk factor for the development of osteonecrosis, which is the most frequent type of damage in lupus patients.